|
Volumn 30, Issue 1, 2007, Pages 181-
|
Effects of angiotensin II type 1 receptor blockade on β-cell function in humans [1]
d
GlaxoSmithKline
*
e
PFIZER
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN 2 RECEPTOR;
GLUCOSE;
INSULIN;
PLACEBO;
VALSARTAN;
APOPTOSIS;
B LYMPHOCYTE;
BLOOD FLOW;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
DRUG INHIBITION;
GLUCOSE CLAMP TECHNIQUE;
HUMAN;
IMPAIRED GLUCOSE TOLERANCE;
INSULIN RELEASE;
INSULIN RESPONSE;
INSULIN SENSITIVITY;
INSULIN SYNTHESIS;
LETTER;
LYMPHOCYTE FUNCTION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
RANDOMIZED CONTROLLED TRIAL;
RECEPTOR BLOCKING;
SPECIES DIFFERENCE;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
HUMANS;
INSULIN;
INSULIN-SECRETING CELLS;
RECEPTOR, ANGIOTENSIN, TYPE 1;
TETRAZOLES;
VALINE;
|
EID: 33845982928
PISSN: 01495992
EISSN: 01495992
Source Type: Journal
DOI: 10.2337/dc06-1745 Document Type: Letter |
Times cited : (15)
|
References (6)
|